TGA
Pholcodine cancelled, recalled
The TGA is recalling 55 products containing pholcodine from pharmacy shelves – and cancelling them from the ARTG The Therapeutic Goods Administration conducted a safety investigation into the pholcodine products, …
Provisional approval for adolescent bivalent booster
Moderna’s bivalent Covid-19 vaccine (elasomeran and davesomeran) has been granted provisional approval for use as a booster in adolescents aged 12 years and older The vaccine is the second targeting …
Skerritt estimates hearing suspended five times
Outgoing Therapeutic Goods Administration (TGA) boss, Professor John Skerritt, endured an interrupted appearance at Senate Estimates yesterday The hearing was suspended five times in the space of an hour, as …
Ozempic about to hit shelves… but there’s a catch
The TGA has announced that supplies of Ozempic (semaglutide) have begun being distributed—but pharmacies will have to be subject to purchasing limits Following skyrocketing demand for Ozempic due at least …
Avoid pregabalin during pregnancy: TGA
“Risk of major congenital malformations” prescribers warned as drug moved to pregnancy Category D The Therapeutic Goods Administration (TGA) has strengthened its warnings around epilepsy and pain drug pregabalin for …
‘Our members understand the impacts of paracetamol poisoning.’
Pharmacists working in hospital have a real understanding of the consequences of paracetamol poisoning, says the SHPA Last month (3 February), the Therapeutic Goods Administration announced its interim decision to …
Keeping to the schedule
Scheduling decisions for ibuprofen, S3 melatonin, S3 fexofenadine and S2 brimonidine announced Decisions around the scheduling of a range of medicines have been announced with the release of interim decisions …
What now for psychedelics?
Following the TGA’s decision to reschedule MDMA and psilocybin to S8 for certain specific conditions, what will change for pharmacists? The recent TGA decision means that the two psychedelic substances …
Psilocybin and MDMA to join S8… under certain circumstances
Australia is to recognise psychedelics as medicines, following a TGA decision on psilocybin and MDMA The Therapeutic Goods Administration has announced that it will permit specifically authorised psychiatrists to prescribe …
The week in review
There’s been a lot to keep up with in pharmacy this week, with the Strengthening Medicare Taskforce released, more GP-pharmacy turf wars and moves in industrial action The Strengthening Medicare …
TGA chief’s legacy ‘large’
Professor John Skerritt has announced his decision to retire from his position of Deputy Secretary Health Products Regulation Group The change will be effective from 18 April 2023, Health Minister …
TGA interim decision: reduce paracetamol access
Some paracetamol pack sizes should be reduced, and pharmacist input needed on sales of more than 32 tablets or capsules, the TGA says The Therapeutic Goods Administration has published its …